Thermography is a painless, non invasive, state of the art clinical test without any exposure to radiation and is used as part of an early detection program which gives women of all ages the opportunity to increase their chances of detecting breast disease at an early stage. It is particularly useful for women under 50 where mammography is less effective.
Thermography's role in breast cancer and other breast disorders is to help in early detection and monitoring of abnormal physiology and the establishment of risk factors for the development or existence of cancer. When used with other procedures the best possible evaluation of breast health is made.
This test is designed to improve chances for detecting fast-growing, active tumors in the intervals between mammographic screenings or when mammography is not indicated by screening guidelines for women under 50 years of age.
Uses new ultra-sensitive, high resolution digital infrared cameras.
Thermography demonstrates heat patterns that are strongly indicative of breast abnormality. The test can detect subtle changes in breast temperature that indicate a variety of breast diseases and abnormalities. Once abnormal heat patterns are detected in the breast, follow-up procedures including mammography are necessary to rule out or properly diagnose cancer and a host of other breast diseases such as fibrocystic syndrome.
Canadian researchers recently found that infrared imaging of breast cancers could detect minute temperature variations related to blood flow and demonstrate abnormal patterns associated with the progression of tumors. These images or thermograms of the breast were positive for 83% of breast cancers compared to 61% for clinical breast examination alone and 84% for mammography .
“ The frontier of COX inhibition in breast cancer prevention and treatment is being probed by several lines of evidence. Epidemiologic research demonstrates a 40% to 50% decrease in the risk of breast cancer among women who are chronic users of NSAIDs.”
Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy Jeanne M. Wallace, PhD, CNC
Balance out the affects of omega 6 fatty acid (linoleic acid). Omega 6 fats produce pro-inflammatory compounds which promote tumor growth, foster angiogenesis, and suppress immune function.
Omega-3’s compete w/Omega-6’s for enzymes needed for cancer-promoting metabolites.
Make cancer cells more vulnerable to free-radical attack by making membranes less saturated.
Promote cancer cell self destruction, increasing their rate of die-off and slowing tumor growth.
Dietary Fish Oil and Breast Cancer Progression
The growth of breast cancer cells in culture and in mice is inhibited by omega-3 fatty acids, scientists report in a fast track article in the November 10th International Journal of Cancer.
According to Dr. Rafat A. Siddiqui from the Methodist Research Institute, Clarian Health Partners in Indianapolis, "Omega-3 fatty acids activate an enzyme called sphingomyelinase, which generates the release of ceramide, a compound that ultimately causes cancer cell death.“
Breast tissue is very susceptible to fat soluble toxins. In a National Government (EPA) human adipose study published in 1990 involving 1377 individuals, 100 % of adipose tissue samples contained dioxin, dichlorobenzene, styrene, xylene, and ethylphenol. 76% of samples had PCB’s, benzene and a host of other chemicals.
Many chemicals act as xenoestrogens and many are just plain carcinogenic. DDT derivatives DDE, PCBs and organochlorenes have been found concentrated in cancer tissue.
Detoxification needs to be a primary focal point in the prevention of cancer.
Phase 2 liver detoxification is essential for removal of excess circulating estrogens and xenobiotics as well.
Sugar in all forms, hormones in meat and dairy products, pesticides, non-organic foods, food additives and preservatives (nitrates, nitrites), white flour, iron-fortified cereals, safflower, sunflower, corn oils, margarine, fried foods, processed and refined foods, commercial cereals, soda, fruit juice, alcohol, isolated soy protein and other processed soy products, reduced fat and nonfat dairy products (plain full fat yogurt in small quantities okay).
Protocol for Breast Cancer Nutritional Support
Supplement Recommendations :
Twice Daily Essential Packets
1 packet twice a day (both multi vitamins in the am)
A recent study reported that most Americans weren’t even getting the Recommended Daily Intake 1 (RDI) of vitamins and minerals , much less the optimal levels of them and that this suboptimal intake of vitamins and minerals is a risk factor for many chronic diseases (breast cancer, osteoporosis, heart disease, diabetes, …).
A summary of current research clearly shows that those who don’t supplement with a high quality multivitamin/ mineral and antioxidant formula are at risk for deficiencies 2 .
1 RDI is the recommended amount to avoid diseases of deficiency like scurvy or pellagra, NOT the amount needed for optimal health and to avoid the major diseases of aging like heart disease, osteoporosis, cancer and diabetes.
2 Medical Professionals and Health Care Practitioners looking for more information on the research supporting the above program can contact Designs for Health support and technical department at 800-847-8302 x 105 or via the website, www.designsforhealth.com .
In a study of 166 women undergoing treatment for breast cancer, nearly 70 percent had low levels of vitamin D in their blood, according to a study presented at the American Society of Clinical Oncology's Breast Cancer Symposium in San Francisco. The analysis showed women with late-stage disease and non-Caucasian women had even lower levels.
"Vitamin D is essential to maintaining bone health, and women with breast cancer have accelerated bone loss due to the nature of hormone therapy and chemotherapy. It's important for women and their doctors to work together to boost their vitamin D intake," said Luke Peppone, Ph.D., research assistant professor of Radiation Oncology, at Rochester's James P. Wilmot Cancer Center. Scientists funded by the NCI analyzed vitamin D levels in each woman, and the average level was 27 nanograms per milliliter; more than two-thirds of the women had vitamin deficiency.
Women with breast cancer have low vitamin D levels
Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.
Biochim Biophys Acta. 2002 Apr 15;1581(3):89-99
Conjugated Linoleic Acid (CLA) is a dietary fatty acid that has received considerable attention due to its unique properties in rodent models including anti-cancer, anti-atherogenic and anti-diabetic effects.
Anti-Inflammatory Properties as well as Immune Enhancing Properties
Epidemiological studies demonstrate that too much folic acid may promote the growth of precancerous cells.
Folic acid (synthetic) and folate (natural) has a “U” shaped relationship to the incidence of cancer. Too little folate presents risk for cancer due to deficient methylation, genetic expression and cell differentiation. Too much folate can promote the growth of tumor lesions. The correct
Research is suggesting that the use of folic acid (synthetic) in fortified foods and most nutritional supplements may pose much higher risk than natural folate found in foods and some supplements.
The synthetic folic acid must be converted (reduced) in the body. Many individuals cannot effectively convert the amount of folic acid they are now being exposed to since the introduction of food fortification in the US in 1998, and due to the increased use of nutritional supplements containing folic acid. This may result in a build-up of “unmetabolized” synthetic folic acid in many individuals.